Novago Therapeutics
NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications. NovaGo’s proprietary antibodies block the function of Nogo-A, one of the most potent and well-studied vascular and nerve growth inhibitors.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Novago Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- KH
Kay Hänggi
Scientist · Science
EmailPhone - MM
Michael Maurer
Principal Scientist · Science
EmailPhone - RW
Roger Wetli
Chief Financial Officer · Finance & Accounting
EmailPhone
Showing 3 of 9 verified contacts
Top roles at Novago Therapeutics
7 distinct titles indexed · top 7 shown.
- 1chief financial officer
- 1clinical operations associate
- 1intern
- 1principal scientist
- 1project manager
- 1scientific collaborator
- 1scientist
Sign up to unlock all 9 contacts at Novago Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Novago Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.